Leidos Holdings, Inc. (NYSE:LDOS) Shares Acquired by Atria Investments Inc

Atria Investments Inc raised its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 100.1% in the third quarter, Holdings Channel.com reports. The fund owned 8,837 shares of the aerospace company’s stock after purchasing an additional 4,421 shares during the period. Atria Investments Inc’s holdings in Leidos were worth $1,440,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Millennium Management LLC grew its holdings in shares of Leidos by 156.5% in the second quarter. Millennium Management LLC now owns 1,133,508 shares of the aerospace company’s stock valued at $165,356,000 after purchasing an additional 691,575 shares in the last quarter. Wedge Capital Management L L P NC grew its holdings in shares of Leidos by 1,184.3% in the second quarter. Wedge Capital Management L L P NC now owns 501,868 shares of the aerospace company’s stock valued at $73,213,000 after purchasing an additional 462,792 shares in the last quarter. International Assets Investment Management LLC grew its holdings in shares of Leidos by 24,194.3% in the third quarter. International Assets Investment Management LLC now owns 377,047 shares of the aerospace company’s stock valued at $61,459,000 after purchasing an additional 375,495 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of Leidos by 76.9% in the second quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock valued at $101,942,000 after purchasing an additional 303,775 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Leidos by 138.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 517,498 shares of the aerospace company’s stock valued at $67,840,000 after purchasing an additional 300,486 shares in the last quarter. 76.12% of the stock is currently owned by institutional investors and hedge funds.

Leidos Stock Performance

Shares of Leidos stock opened at $160.63 on Friday. The firm’s fifty day simple moving average is $169.39 and its 200-day simple moving average is $155.25. The stock has a market capitalization of $21.43 billion, a price-to-earnings ratio of 18.00, a PEG ratio of 1.30 and a beta of 0.68. Leidos Holdings, Inc. has a 12 month low of $104.63 and a 12 month high of $202.90. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15.

Leidos (NYSE:LDOS) last announced its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $1.96 by $0.97. The company had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a net margin of 7.37% and a return on equity of 30.31%. Leidos’s quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.03 EPS. As a group, equities analysts forecast that Leidos Holdings, Inc. will post 10.07 earnings per share for the current year.

Leidos Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, December 13th. This represents a $1.60 dividend on an annualized basis and a yield of 1.00%. This is an increase from Leidos’s previous quarterly dividend of $0.38. Leidos’s dividend payout ratio is presently 17.31%.

Insiders Place Their Bets

In other news, Director Surya N. Mohapatra sold 2,748 shares of the stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the transaction, the director now owns 20,001 shares in the company, valued at $3,899,594.97. This trade represents a 12.08 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $184.94, for a total transaction of $193,632.18. Following the completion of the transaction, the director now owns 6,408 shares of the company’s stock, valued at $1,185,095.52. This represents a 14.04 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on LDOS. Barclays lifted their price target on shares of Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Robert W. Baird lifted their price target on shares of Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Bank of America lifted their price target on shares of Leidos from $160.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Citigroup lifted their price target on shares of Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Finally, Wells Fargo & Company boosted their price objective on shares of Leidos from $183.00 to $230.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Two equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Leidos currently has a consensus rating of “Moderate Buy” and a consensus price target of $191.23.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.